Literature DB >> 24850340

The human face of biobank networks for translational research.

Karen Meir1, Eoin F Gaffney, Daniel Simeon-Dubach, Rivka Ravid, Peter H Watson, Brent Schacter, Manuel M Morente And The Marble Arch International Working Group On Biobanking.   

Abstract

The biobanking literature frequently addresses donor and societal issues surrounding biobanking, but the biobanker's perspective is rarely highlighted. While not comprehensive, this article offers an overview of the human aspects of biobanking from the viewpoint of biobank personnel-from biobank formation, through the process, and in addressing post-biobanking issues. As every biobank and biobank network may differ, such factors may vary. Before biobanking can commence, the purpose of the biobank network must be defined, and buy-in achieved from many stakeholders. An attitude of trust and sharing is essential, as is good communication. Developing a biobank is time consuming and laborious. Forming a network requires significantly more time due to the need for cross-institutional harmonization of policies, procedures, information technology considerations, and ethics. Circumstances may dictate whether development occurs top-down and/or bottom-up, as well as whether network management may be independent or by personnel from participating biobanks. Funding tends to be a prominent issue for biobanks and networks alike. In particular, networks function optimally with some level of government support, particularly for personnel. Quality biospecimen collection involves meticulously documented coordination with a network of medical and nursing staff. Examining and sampling operative specimens requires timely collaboration between the surgical and pathology teams. "Catch rates" for samples may be difficult to predict and may occur at a frequency less than anticipated due to factors related to the institution, staff, or specimen. These factors may affect specimen quality, and have a downstream effect on competition for specimens for research. Thus, release of samples requires a fair, carefully constructed sample access policy, usually incorporating an incentive for researchers, and an encouragement to form collaborations. Finally, the public and patient groups should aim to understand the benefits of a biobank network, so that patient care is improved through coordinated biobanking activity.

Entities:  

Year:  2011        PMID: 24850340     DOI: 10.1089/bio.2011.0018

Source DB:  PubMed          Journal:  Biopreserv Biobank        ISSN: 1947-5543            Impact factor:   2.300


  5 in total

1.  Realizing Our Potential in Biobanking: Disease Advocacy Organizations Enliven Translational Research.

Authors:  Kelly A Edwards; Sharon F Terry; Dana Gold; Elizabeth J Horn; Mary Schwartz; Molly Stuart; Suzanne D Vernon
Journal:  Biopreserv Biobank       Date:  2016-04-08       Impact factor: 2.300

Review 2.  Development and progress of Ireland's biobank network: Ethical, legal, and social implications (ELSI), standardized documentation, sample and data release, and international perspective.

Authors:  Blanaid Mee; Eoin Gaffney; Sharon A Glynn; Simona Donatello; Paul Carroll; Elizabeth Connolly; Sarah Mc Garrigle; Terry Boyle; Delia Flannery; Francis J Sullivan; Paul McCormick; Mairead Griffin; Cian Muldoon; Joanna Fay; Tony O'Grady; Elaine Kay; Joe Eustace; Louise Burke; Asim A Sheikh; Stephen Finn; Richard Flavin; Francis J Giles
Journal:  Biopreserv Biobank       Date:  2013-02       Impact factor: 2.300

3.  Assessment of knowledge about biobanking among healthcare students and their willingness to donate biospecimens.

Authors:  Leena Merdad; Lama Aldakhil; Rawan Gadi; Mourad Assidi; Salina Y Saddick; Adel Abuzenadah; Jim Vaught; Abdelbaset Buhmeida; Mohammed H Al-Qahtani
Journal:  BMC Med Ethics       Date:  2017-05-02       Impact factor: 2.652

4.  Prospective Real-World Gynaecological Cancer Clinical Registry with Associated Biospecimens: A Collaborative Model to Promote Translational Research between GEICO and the Spanish Biobank Network.

Authors:  José Antonio López-Guerrero; Marta Mendiola; José Alejandro Pérez-Fidalgo; Ignacio Romero; Ana Torres; Delia Recalde; Elena Molina; César Gómez-Raposo; Ana M Levin; Ana Herrero; Jesús Alarcón; Carmen Esteban; Gloria Marquina; María Jesús Rubio; Eva Guerra; Luisa Sánchez-Lorenzo; Fernando Gálvez-Montosa; Ana de Juan; Cristina Churruca; Alejandro Gallego; Antonio González-Martín
Journal:  Cancers (Basel)       Date:  2022-04-13       Impact factor: 6.639

5.  Assessment of Biobanking Knowledge and Attitudes towards Biospecimen Donation among Healthcare Providers in Saudi Arabia.

Authors:  Abdelbaset Buhmeida; Mourad Assidi; Omar Alyazidi; Duaa Ibrahim Olwi; Ahmed Althuwaylimi; Fatimah M Yahya; Leila Arfaoui; Leena Merdad; Adel Mohammad Abuzenadah
Journal:  Int J Environ Res Public Health       Date:  2022-09-20       Impact factor: 4.614

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.